State-of-the-Art Review: Recurrent Uncomplicated Urinary Tract Infections in Women
- PMID: 40095960
- PMCID: PMC11912977
- DOI: 10.1093/cid/ciae653
State-of-the-Art Review: Recurrent Uncomplicated Urinary Tract Infections in Women
Abstract
Over 50% of adult women experience at least 1 urinary tract infection (UTI) in their lifetime, and almost one-quarter of them will experience a recurrent UTI (rUTI). Recurrent UTI is defined as ≥2 UTIs in a 6-month period or ≥3 UTIs in 12 months (at least 1 of these episodes should be culture-proven to confirm infectious etiology). In this narrative review, we discuss the epidemiology, pathogenesis, diagnosis, and treatment considerations for recurrent uncomplicated cystitis in the adult female population. We provide a focused overview of the comprehensive management of these patients, with input from infectious disease physicians, urogynecologists, and urologists with expertise in rUTI, highlighting updated recommendations by the Infectious Diseases Society of America, American Urologic Association, Canadian Urologic Association, and American Urogynecologic Society. Finally, given the variety of prevention strategies, different treatment goals, and the need for "preference sensitive" decisions, we highlight the need for shared decision-making with patients.
Keywords: LUTS; asymptomatic bacteriuria; chronic UTI; recurrent UTI; recurrent cystitis.
© The Author(s) 2025. Published by Oxford University Press on behalf of Infectious Diseases Society of America. All rights reserved. For commercial re-use, please contact reprints@oup.com for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site—for further information please contact journals.permissions@oup.com.
Conflict of interest statement
Potential conflicts of interest. Dr Advani reports support from Centers for Disease Control and Prevention (SHEPheRD 75D30121D12733-D5-E003 and 5U54CK000616-02), the Society for Healthcare Epidemiology of America, and the Duke Claude D. Pepper Older Americans Independence Center (National Institute on Aging grant no. P30AG028716), as well as past consulting fees from Locus Biosciences, Sysmex America, GlaxoSmithKline, bioMérieux, and the Infectious Diseases Society of America. Dr. Advani became an employee of GSK/ViiV Healthcare after submission of this manuscript. Dr. Siddiqui reports ongoing research support from Medtronic, Inc. and Ethicon Johnson & Johnson, consulting fees from Boston Scientific, royalties from UpToDate, and serves on the Board of Directors for the American Urogynecologic Society. All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed.
References
-
- Peck J, Shepherd JP. Recurrent urinary tract infections: diagnosis, treatment, and prevention. Obstet Gynecol Clin North Am 2021; 48:501–13. - PubMed
-
- Brubaker L, Carberry C, Nardos R, Carter-Brooks C, Lowder JL. American Urogynecologic Society best-practice statement: recurrent urinary tract infection in adult women. Female Pelvic Med Reconstr Surg 2018; 24:321–35. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- Boston Scientific
- American Urogynecologic Society
- Infectious Diseases Society of America
- Locus Biosciences
- P30AG028716/AG/NIA NIH HHS/United States
- K08 AI171183/AI/NIAID NIH HHS/United States
- Society for Healthcare Epidemiology of America
- 75D30121D12733-D5-E003/CC/CDC HHS/United States
- K12DK100024/DK/NIDDK NIH HHS/United States
- U54 CK000616/CK/NCEZID CDC HHS/United States
- K12 DK100024/DK/NIDDK NIH HHS/United States
- bioMérieux
- GlaxoSmithKline
- Duke Claude D. Pepper Older Americans Independence Center
- Sysmex America
- P30 AG028716/AG/NIA NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
